These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Results of a one-year open trial of cyclosporine in ten patients with severe myasthenia gravis. Goulon M; Elkharrat D; Lokiec F; Gajdos P Transplant Proc; 1988 Jun; 20(3 Suppl 4):211-7. PubMed ID: 3260050 [No Abstract] [Full Text] [Related]
4. Scientific overview of myasthenia gravis and an assessment of the role of plasmapheresis. Tindall RS Prog Clin Biol Res; 1982; 106():113-42. PubMed ID: 6757936 [No Abstract] [Full Text] [Related]
5. [Myasthenia gravis. New results on etiology, diagnosis and therapy]. Jerusalem F Schweiz Med Wochenschr; 1977 Jan; 107(3):65-8. PubMed ID: 402021 [TBL] [Abstract][Full Text] [Related]
7. [Therapy of myasthenia gravis]. Henze T Dtsch Med Wochenschr; 1986 Mar; 111(13):507-9. PubMed ID: 3956394 [No Abstract] [Full Text] [Related]
8. Myasthenia gravis (second of two parts). Drachman DB N Engl J Med; 1978 Jan; 298(4):186-93. PubMed ID: 339085 [No Abstract] [Full Text] [Related]
9. [Amount of circulating acetylcholine receptor antibodies in the course of myasthenia, following thymectomy and in immunosuppressive therapy]. Patzold U; Kalies I; Haas J; Ginda EM Nervenarzt; 1984 Aug; 55(8):426-31. PubMed ID: 6483064 [No Abstract] [Full Text] [Related]
10. Immunochemical analysis of acetylcholine receptor and its relevance to specific treatment of experimental autoimmune myasthenia gravis. Fuchs S Adv Cytopharmacol; 1979; 3():279-85. PubMed ID: 382790 [No Abstract] [Full Text] [Related]
11. [Myasthenia gravis in newborn infants--pathological mechanism, clinical symptomatology and therapeutic procedures]. Krauze M; Musialik E; Swietliński J; Litwa K; Latko E; Górny J; Sobczyk J Wiad Lek; 1992 Aug; 45(15-16):610-4. PubMed ID: 1488831 [TBL] [Abstract][Full Text] [Related]
12. The role of plasma exchange in treatment of myasthenia gravis. Dau PC Prog Clin Biol Res; 1982; 106():143-56. PubMed ID: 7178136 [No Abstract] [Full Text] [Related]
13. Biology of myasthenia gravis. Lindstrom J; Dau P Annu Rev Pharmacol Toxicol; 1980; 20():337-62. PubMed ID: 6992700 [No Abstract] [Full Text] [Related]
15. Current treatment of myasthenia gravis. Osterman PO Prog Brain Res; 1990; 84():151-61. PubMed ID: 2267293 [No Abstract] [Full Text] [Related]
16. [Clinicopathological studies on myasthenia gravis and thymus]. Kawaguchi T; Tani A; Koie H Kokyu To Junkan; 1988 Oct; 36(10):1101-4. PubMed ID: 3247525 [No Abstract] [Full Text] [Related]
17. [Plasma exchange combined with immunosuppressive therapy in myasthenia gravis]. Tanaka M; Nagai H; Mori S; Miyatake T; Shinada S No To Shinkei; 1982 Jul; 34(7):699-703. PubMed ID: 7138697 [No Abstract] [Full Text] [Related]
18. Myasthenia gravis and acetylcholine receptor: autoimmunity and steroid effects. Abramsky O Int J Neurol; 1980; 14(1):25-34. PubMed ID: 6293989 [No Abstract] [Full Text] [Related]
19. The course of myasthenia gravis in patients treated with corticosteroids, azathioprine, and plasmapheresis. Cornelio F; Peluchetti D; Mantegazza R; Sghirlanzoni A; Collarile C Ann N Y Acad Sci; 1987; 505():517-25. PubMed ID: 3479934 [No Abstract] [Full Text] [Related]
20. Managing patients who have myasthenia gravis. Johns TR West J Med; 1985 Jun; 142(6):810-3. PubMed ID: 4024633 [No Abstract] [Full Text] [Related] [Next] [New Search]